Responsive afatinib treatment in high-grade salivary gland ductal carcinoma and NSCLC with uncommon EGFR mutations: Treatment outcomes

Responsive afatinib treatment in high-grade salivary gland ductal carcinoma and NSCLC with uncommon EGFR mutations: Treatment outcomes

In recent years, targeted therapies have revolutionized cancer treatment, particularly for tumors with specific genetic alterations. High-grade salivary gland ductal carcinoma and non-small cell lung cancer (NSCLC) are two distinct malignancies characterized by unique challenges but share uncommon e...

Full description

Saved in:
Bibliographic Details
Main Author: Sivakamavalli Jeyachandran
Format: Article
Language:English
Published: Elsevier 2024-06-01
Series:Oral Oncology Reports
Subjects:
NSCLC
EGFR
Afatinib
Salivary gland
Online Access:http://www.sciencedirect.com/science/article/pii/S2772906024003856
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items